Medicare Won’t Expand Coverage of Anti-Obesity Drugs

Medicare won’t cover anti-obesity drugs like Ozempic and Zepbound for its beneficiaries, the Centers for Medicare and Medicaid Services have announced

You May Also Like

More From Author